These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26946363)

  • 1. Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravis.
    Yamada C; Pham HP; Wu Y; Cooling L; Kim HC; Morgan S; Schwartz J; Winters JL; Wong EC
    J Clin Apher; 2017 Feb; 32(1):5-11. PubMed ID: 26946363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy for anti-MuSK antibody positive myasthenia gravis].
    Pál Z; Boczán J; Bereznai B; Lovas G; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1586-9. PubMed ID: 21920845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of therapeutic plasma exchange by using apheresis devices in pediatric atypical hemolytic uremic syndrome patients.
    Hans R; Sharma RR; Marwaha N; Suri D; Kumar R; Gupta A; Singh S
    J Clin Apher; 2016 Aug; 31(4):381-7. PubMed ID: 26212115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H; Motomura M; Yoshimura T; Shiraishi H; Mitsui Y; Hasegawa T; Atsumi M; Kitaguchi M; Kusunoki S
    Rinsho Shinkeigaku; 2005 Jul; 45(7):510-3. PubMed ID: 16119834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
    Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
    Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status.
    Usmani A; Kwan L; Wahib-Khalil D; Trivedi J; Nations S; Sarode R
    J Clin Apher; 2019 Aug; 34(4):416-422. PubMed ID: 30779438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of pediatric plasma apheresis in intensive care settings.
    Haque A; Sher G; Hoda M; Moiz B
    Ther Apher Dial; 2014 Oct; 18(5):497-501. PubMed ID: 24674133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the ASFA apheresis registry study on Wilson's disease.
    Pham HP; Schwartz J; Cooling L; Hofmann JC; Kim HC; Morgan S; Pagano MB; Schneiderman J; Winters JL; Yamada C; Wong EC; Wu Y
    J Clin Apher; 2016 Feb; 31(1):11-5. PubMed ID: 26275240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
    Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
    Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete stable remission and autoantibody specificity in myasthenia gravis.
    Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
    Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
    Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
    Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.
    Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC
    J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged improvement after rituximab: two cases of resistant muscle-specific receptor tyrosine kinase + myasthenia gravis.
    Burusnukul P; Brennan TD; Cupler EJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):85-7. PubMed ID: 21386776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of complications of therapeutic plasma exchange in myasthenia.
    Guptill JT; Oakley D; Kuchibhatla M; Guidon AC; Hobson-Webb LD; Massey JM; Sanders DB; Juel VC
    Muscle Nerve; 2013 Feb; 47(2):170-6. PubMed ID: 23168720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.